Belgian Red Cross

The Belgian Red Cross is a leading independent humanitarian organisation in Belgium and a member of the International Red Cross and Red Crescent Movement, founded in 1864.. Building on its long-standing expertise in blood processing, Belgian Red Cross has developed Lysantum®, a patented human platelet lysate (HPL) produced from surplus donor platelets as a xeno-free alternative to Fetal Bovine Serum (FBS). Manufactured under GMP-aligned conditions with full European traceability, Lysantum delivers high consistency, safety, and scalability. Its fibrinogen-depleted, pathogen-inactivated formulation supports robust and reproducible cell expansion across a wide range of cell types. With reliable supply and growth kinetics up to twice as fast as FBS, it enables more efficient and cost-effective development.